药石科技(300725)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300725 药石科技

已收盘 09-24 15:00:00

{"stockData":{"symbol":"300725","market":"SZ","secType":"STK","nameCN":"药石科技","latestPrice":52.08,"timestamp":1790233386000,"preClose":54.35,"halted":0,"volume":28255490,"delay":0,"changeRate":-0.0418,"floatShares":202999999,"shares":234000000,"eps":0.9011,"marketStatus":"已收盘","change":-2.27,"latestTime":"09-24 15:00:00","open":53.94,"high":55.55,"low":52,"amount":1508000000,"amplitude":0.0653,"askPrice":52.09,"askSize":40,"bidPrice":52.08,"bidSize":162,"shortable":0,"etf":0,"ttmEps":0.9011,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790559000000},"marketStatusCode":5,"adr":0,"adjPreClose":54.35,"symbolType":"stock","openAndCloseTimeList":[[1790213400000,1790220600000],[1790226000000,1790233200000]],"highLimit":59.79,"lowLimit":48.92,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":233807341,"isCdr":false,"pbRate":2.78,"roa":"--","peRate":57.796027,"roe":"1.82%","epsLYR":0.88,"committee":-0.039604,"marketValue":12177000000,"turnoverRate":0.1394,"status":1,"floatMarketCap":10558000000},"requestUrl":"/m/hq/s/300725/","defaultTab":"news","newsList":[{"id":"2669416159","title":"9月21日药石科技涨6.57%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669416159","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669416159?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:46","pubTimestamp":1789980415,"startTime":"0","endTime":"0","summary":"证券之星消息，9月21日药石科技涨6.57%，收盘报50.32元，换手率13.78%，成交量27.93万手，成交额13.91亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A目前规模为1.11亿元，最新净值2.344，较上一交易日上涨1.38%，近一年下跌14.2%。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100021034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159443","title":"药石科技涨6.57%，开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159443?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:46","pubTimestamp":1789980401,"startTime":"0","endTime":"0","summary":"今日药石科技涨6.57%，收盘报50.32元。2026年8月17日，开源证券研究员余汝意发布了对药石科技的研报《公司信息更新报告：盈利修复逐季验证，订单增长带来收入弹性》，该研报对药石科技给出“买入”评级。研报中预计2026-2028年公司归母净利润为2.49/3.34/4.12亿元，EPS为1.07/1.43/1.76元，当前股价对应PE为51.3/38.4/31.1倍，公司作为国内稀缺的CRDMO一体化平台，在手订单与项目管线持续积累支撑中长期成长，维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100021026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667855279","title":"药石科技：截至2026年9月10日，公司股东人数51,488名","url":"https://stock-news.laohu8.com/highlight/detail?id=2667855279","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667855279?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:51","pubTimestamp":1789563075,"startTime":"0","endTime":"0","summary":"证券之星消息，药石科技09月15日在投资者关系平台上答复投资者关心的问题。截至2026年9月10日，公司股东人数51,488名。公司股票价格受行业环境、市场走势及投资者预期等多方面因素影响。互动易不属于法定信息披露渠道，关于股份减持、增发等事项，如有相关计划，公司将严格按照相关法律法规履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600035310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667611289","title":"研报掘金丨华源证券：首予药石科技“买入”评级，管线后移有望驱动收入放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2667611289","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667611289?lang=zh_cn&edition=full","pubTime":"2026-09-15 14:40","pubTimestamp":1789454417,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300725","161027","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667590076","title":"9月14日药石科技涨8.34%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667590076","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667590076?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:41","pubTimestamp":1789375279,"startTime":"0","endTime":"0","summary":"证券之星消息，9月14日药石科技涨8.34%，收盘报44.55元，换手率11.12%，成交量22.55万手，成交额9.82亿元。重仓药石科技的公募基金请见下表：该股最近90天内共有6家机构给出评级，买入评级4家，增持评级2家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667590296","title":"药石科技涨8.34%，开源证券四周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2667590296","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667590296?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:41","pubTimestamp":1789375270,"startTime":"0","endTime":"0","summary":"今日药石科技涨8.34%，收盘报44.55元。2026年8月17日，开源证券研究员余汝意发布了对药石科技的研报《公司信息更新报告：盈利修复逐季验证，订单增长带来收入弹性》，该研报对药石科技给出“买入”评级。研报中预计2026-2028年公司归母净利润为2.49/3.34/4.12亿元，EPS为1.07/1.43/1.76元，当前股价对应PE为51.3/38.4/31.1倍，公司作为国内稀缺的CRDMO一体化平台，在手订单与项目管线持续积累支撑中长期成长，维持“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021214.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666542136","title":"药石科技：南京CDMO创新基地项目旨在进一步完善公司CDMO产业布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2666542136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666542136?lang=zh_cn&edition=full","pubTime":"2026-09-11 16:09","pubTimestamp":1789114168,"startTime":"0","endTime":"0","summary":"南京CDMO创新基地项目旨在进一步完善公司CDMO产业布局，依托南京研发总部及开发团队，强化研发、开发与生产转化之间的协同能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100033502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666959295","title":"药石科技：公司股票价格受行业环境、市场走势及投资者预期等多方面因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2666959295","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666959295?lang=zh_cn&edition=full","pubTime":"2026-09-10 20:48","pubTimestamp":1789044495,"startTime":"0","endTime":"0","summary":"证券之星消息，药石科技09月09日在投资者关系平台上答复投资者关心的问题。谢谢药石科技回复：尊敬的投资者，您好！公司股票价格受行业环境、市场走势及投资者预期等多方面因素影响。公司始终专注于主营业务发展，持续推进研发创新和经营管理工作，努力提升公司长期价值。互动易不属于法定信息披露渠道，关于股份回购、增减持等事项，如有相关计划，公司将严格按照相关法律法规履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000039879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666895375","title":"药石科技：南京CDMO创新基地建设项目正有序推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2666895375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666895375?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:09","pubTimestamp":1788944956,"startTime":"0","endTime":"0","summary":"证券之星消息，药石科技(300725)09月09日在投资者关系平台上答复投资者关心的问题。投资者提问：公司股价一路下跌，已经连续10连阴，请公司及时披露与江北生物产业园的最新投资细节，稳定二级市场。药石科技回复：尊敬的投资者，您好！公司股票价格受行业环境、市场走势及投资者预期等多方面因素影响。关于南京CDMO创新基地建设项目，公司已履行相关审议及信息披露程序，目前正按照既定计划有序推进相关工作。后续如有达到信息披露标准的进展事项，公司将及时履行信息披露义务。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900028603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665233343","title":"药石科技：南京CDMO创新基地项目已经前期审慎论证","url":"https://stock-news.laohu8.com/highlight/detail?id=2665233343","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665233343?lang=zh_cn&edition=full","pubTime":"2026-09-08 15:51","pubTimestamp":1788853899,"startTime":"0","endTime":"0","summary":"证券之星消息，药石科技09月08日在投资者关系平台上答复投资者关心的问题。谢谢药石科技回复：您好，公司股票价格受行业环境、市场走势及投资者预期等多方面因素影响。南京CDMO创新基地项目已经前期审慎论证，具备相应的实施基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800021676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871175","title":"药石科技：第四届董事会第十七次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871175","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664871175?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:22","pubTimestamp":1788434520,"startTime":"0","endTime":"0","summary":"证券日报网讯9月3日，药石科技发布公告称，公司于2026年9月3日召开第四届董事会第十七次会议，审议通过《关于拟签署投资合作协议暨投资建设南京CDMO创新基地的议案》。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-03/doc-iniqqfvs6735804.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-03/doc-iniqqfvs6735804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664987342","title":"药石科技最新公告：拟投资20亿元建设南京CDMO创新基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2664987342","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664987342?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:45","pubTimestamp":1788428733,"startTime":"0","endTime":"0","summary":"药石科技(300725.SZ)公告称，公司拟与南京江北新材料科技园有限公司签署投资合作协议，共同出资设立项目公司，参与南京江北新材料科技园内相关地块竞买，推进南京CDMO创新基地项目实施。项目整体投资预计约20亿元，其中项目公司基础设施投资暂估约8亿元，承租方后续运营投入约12亿元。项目公司注册资本1.6亿元，公司持股70%，新材料科技园公司持股30%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300032431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664349128","title":"药石科技：公司不涉及应披露而未披露的信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2664349128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664349128?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:18","pubTimestamp":1788250693,"startTime":"0","endTime":"0","summary":"证券之星消息，药石科技09月01日在投资者关系平台上答复投资者关心的问题。经核查，公司不涉及应披露而未披露的信息。公司所有重大信息均以公司在指定信息披露媒体披露的公告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100027237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663907042","title":"股市必读：药石科技（300725）8月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2663907042","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663907042?lang=zh_cn&edition=full","pubTime":"2026-08-31 02:02","pubTimestamp":1788112936,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，药石科技报收于45.5元，下跌2.84%，换手率7.99%，成交量16.19万手，成交额7.45亿元。董秘： 投资者您好，您此前提出的同类问题，公司已于2026年8月5日在互动易平台作出回复，请参阅相关回复。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100000708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662821917","title":"药石科技：公司暂无法获取回复日前一交易日的股东人数","url":"https://stock-news.laohu8.com/highlight/detail?id=2662821917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662821917?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:18","pubTimestamp":1787645890,"startTime":"0","endTime":"0","summary":"证券之星消息，药石科技(300725)08月25日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，麻烦公布一下最新的股东人数情况，谢谢，以您回复日期的前一个收盘日为准（不是我提问日期），非常感谢药石科技回复：根据中国证券登记结算有限责任公司业务规则，中登公司每月分三次下发定期持有人名册，固定统计时点为上月末、本月 10 日、本月 20 日（非交易日顺延至前一交易日），公司暂无法获取回复日前一交易日的股东人数。敬请理解，感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500032147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224382","title":"8月24日药石科技跌6.12%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661224382?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:41","pubTimestamp":1787560877,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日药石科技跌6.12%，收盘报48.31元，换手率11.52%，成交量23.35万手，成交额11.47亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A目前规模为1.11亿元，最新净值2.421，较上一交易日下跌2.54%，近一年下跌13.54%。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400022135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661269020","title":"药石科技(300725)8月10日股东户数5.29万户，较上期增加13.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661269020","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661269020?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:47","pubTimestamp":1787305676,"startTime":"0","endTime":"0","summary":"证券之星消息，近日药石科技披露，截至2026年8月10日公司股东户数为5.29万户，较7月20日增加6324.0户，增幅为13.59%。户均持股数量由上期的5024.0股减少至4423.0股，户均持股市值为21.94万元。在医疗服务行业个股中，药石科技股东户数高于行业平均水平，截至8月10日，医疗服务行业平均股东户数为4.8万户。根据统计，药石科技2026年7月20日至2026年8月10日，主力资金净流出3.42亿元，游资资金净流出1.64亿元，散户资金净流入5.06亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100032887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661248265","title":"8月21日药石科技跌5.37%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661248265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661248265?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:47","pubTimestamp":1787302020,"startTime":"0","endTime":"0","summary":"证券之星消息，8月21日药石科技跌5.37%，收盘报51.46元，换手率15.21%，成交量30.84万手，成交额16.12亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A目前规模为1.11亿元，最新净值2.484，较上一交易日上涨3.89%，近一年下跌11.6%。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100029691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250227","title":"药石科技：截至2026年8月10日，公司股东人数52,862名","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250227","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661250227?lang=zh_cn&edition=full","pubTime":"2026-08-21 15:21","pubTimestamp":1787296867,"startTime":"0","endTime":"0","summary":"证券之星消息，药石科技(300725)08月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问一下截止到八月十二日收盘，贵公司的股东人数是多少？谢谢药石科技回复：投资者您好，截至2026年8月10日，公司股东人数52,862名。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100022164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660097402","title":"药石科技涨9.84%，开源证券三日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2660097402","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660097402?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:43","pubTimestamp":1787215407,"startTime":"0","endTime":"0","summary":"今日药石科技涨9.84%，收盘报54.38元。2026年8月17日，开源证券研究员余汝意发布了对药石科技的研报《公司信息更新报告：盈利修复逐季验证，订单增长带来收入弹性》，该研报对药石科技给出“买入”评级。研报中预计2026-2028年公司归母净利润为2.49/3.34/4.12亿元，EPS为1.07/1.43/1.76元，当前股价对应PE为51.3/38.4/31.1倍，公司作为国内稀缺的CRDMO一体化平台，在手订单与项目管线持续积累支撑中长期成长，维持“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000029023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","161027"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790490787594,"stockEarnings":[{"period":"1week","weight":0.1246},{"period":"1month","weight":0.0603},{"period":"3month","weight":0.5574},{"period":"6month","weight":0.4731},{"period":"1year","weight":0.2729},{"period":"ytd","weight":0.3654}],"compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":-0.0003},{"period":"3month","weight":-0.0345},{"period":"6month","weight":-0.0065},{"period":"1year","weight":0.009},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京药石科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"51488人(较上一季度减少2.60%)","perCapita":"3937股","listingDate":"2017-11-10","address":"江苏省南京市浦口区江北新区华盛路81号","registeredCapital":"23380万元","survey":"　　南京药石科技股份有限公司的主营业务是提供覆盖从早期药物发现到商业化生产的全流程服务。公司的主要产品是药物研究阶段的产品与服务、药物开发阶段的产品和服务、新分子实体（OPC）业务、绿色与智能技术平台。","listedPrice":11.32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药石科技(300725)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药石科技(300725)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药石科技,300725,药石科技股票,药石科技股票老虎,药石科技股票老虎国际,药石科技行情,药石科技股票行情,药石科技股价,药石科技股市,药石科技股票价格,药石科技股票交易,药石科技股票购买,药石科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药石科技(300725)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药石科技(300725)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}